Lipella Pharmaceuticals (LIPO) Competitors $2.46 +0.05 (+2.07%) (As of 01:56 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends LIPO vs. AWH, TLPH, TSBX, CDT, INDP, PHXM, KPRX, IPA, MBIO, and SNTIShould you be buying Lipella Pharmaceuticals stock or one of its competitors? The main competitors of Lipella Pharmaceuticals include Aspira Women's Health (AWH), Talphera (TLPH), Turnstone Biologics (TSBX), Conduit Pharmaceuticals (CDT), Indaptus Therapeutics (INDP), PHAXIAM Therapeutics (PHXM), Kiora Pharmaceuticals (KPRX), ImmunoPrecise Antibodies (IPA), Mustang Bio (MBIO), and Senti Biosciences (SNTI). These companies are all part of the "pharmaceutical products" industry. Lipella Pharmaceuticals vs. Aspira Women's Health Talphera Turnstone Biologics Conduit Pharmaceuticals Indaptus Therapeutics PHAXIAM Therapeutics Kiora Pharmaceuticals ImmunoPrecise Antibodies Mustang Bio Senti Biosciences Aspira Women's Health (NASDAQ:AWH) and Lipella Pharmaceuticals (NASDAQ:LIPO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings. Which has stronger earnings & valuation, AWH or LIPO? Lipella Pharmaceuticals has lower revenue, but higher earnings than Aspira Women's Health. Aspira Women's Health is trading at a lower price-to-earnings ratio than Lipella Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspira Women's Health$9.15M1.30-$16.69M-$1.20-0.62Lipella Pharmaceuticals$450K6.61-$4.62M-$4.25-0.58 Is AWH or LIPO more profitable? Aspira Women's Health has a net margin of -165.07% compared to Lipella Pharmaceuticals' net margin of -882.82%. Aspira Women's Health's return on equity of 0.00% beat Lipella Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Aspira Women's Health-165.07% N/A -255.28% Lipella Pharmaceuticals -882.82%-192.33%-154.24% Do analysts prefer AWH or LIPO? Aspira Women's Health presently has a consensus target price of $4.40, indicating a potential upside of 494.59%. Lipella Pharmaceuticals has a consensus target price of $16.00, indicating a potential upside of 550.41%. Given Lipella Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Lipella Pharmaceuticals is more favorable than Aspira Women's Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspira Women's Health 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Lipella Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of AWH or LIPO? 12.2% of Aspira Women's Health shares are owned by institutional investors. Comparatively, 74.3% of Lipella Pharmaceuticals shares are owned by institutional investors. 4.3% of Aspira Women's Health shares are owned by insiders. Comparatively, 32.1% of Lipella Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk and volatility, AWH or LIPO? Aspira Women's Health has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Lipella Pharmaceuticals has a beta of 0.31, indicating that its stock price is 69% less volatile than the S&P 500. Does the MarketBeat Community favor AWH or LIPO? Aspira Women's Health received 13 more outperform votes than Lipella Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Lipella Pharmaceuticals an outperform vote while only 20.00% of users gave Aspira Women's Health an outperform vote. CompanyUnderperformOutperformAspira Women's HealthOutperform Votes1420.00% Underperform Votes5680.00% Lipella PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo Votes Does the media favor AWH or LIPO? In the previous week, Aspira Women's Health had 3 more articles in the media than Lipella Pharmaceuticals. MarketBeat recorded 6 mentions for Aspira Women's Health and 3 mentions for Lipella Pharmaceuticals. Aspira Women's Health's average media sentiment score of 0.26 beat Lipella Pharmaceuticals' score of -0.55 indicating that Aspira Women's Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aspira Women's Health 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lipella Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative SummaryLipella Pharmaceuticals beats Aspira Women's Health on 9 of the 17 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Lipella Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LIPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIPO vs. The Competition Export to ExcelMetricLipella PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.98M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.585.5095.1214.22Price / Sales6.61375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book2.0310.276.976.37Net Income-$4.62M$153.22M$118.73M$225.56M7 Day Performance-3.15%-1.19%-1.22%-0.02%1 Month Performance-37.19%-6.71%-3.07%2.04%1 Year Performance-72.79%32.39%32.52%28.00% Lipella Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIPOLipella Pharmaceuticals2.9867 of 5 stars$2.46+2.1%$16.00+550.4%-74.3%$2.98M$450,000.00-0.584News CoverageAWHAspira Women's Health1.533 of 5 stars$0.74+1.4%$4.40+494.6%-78.5%$11.88M$9.15M-0.64110Analyst ForecastTLPHTalphera2.6915 of 5 stars$0.69-2.3%$4.50+552.1%N/A$11.75M$650,000.000.0019Gap UpTSBXTurnstone Biologics3.2023 of 5 stars$0.48+4.4%$2.13+342.7%-84.8%$11.10M$19.31M0.0082CDTConduit PharmaceuticalsN/A$0.11+21.0%N/A-92.8%$10.72MN/A0.003News CoverageGap UpHigh Trading VolumeINDPIndaptus Therapeutics2.7304 of 5 stars$1.05-1.4%$8.50+713.4%-48.7%$10.66MN/A0.006PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049KPRXKiora Pharmaceuticals2.9909 of 5 stars$3.38-1.2%$10.00+195.9%-32.4%$10.14MN/A0.0010IPAImmunoPrecise Antibodies2.0348 of 5 stars$0.35-9.3%$6.00+1,614.3%-72.2%$10.09M$18.16M0.0080MBIOMustang Bio1.9526 of 5 stars$0.21+0.4%$2.00+852.8%-87.6%$10.03MN/A-0.13100SNTISenti Biosciences1.0644 of 5 stars$2.16+1.9%N/A-42.1%$9.91M$2.56M-0.144News Coverage Related Companies and Tools Related Companies AWH Competitors TLPH Competitors TSBX Competitors CDT Competitors INDP Competitors PHXM Competitors KPRX Competitors IPA Competitors MBIO Competitors SNTI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LIPO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIPO Stock Alerts